YWP
MDCO

YorkBridge Wealth Partners’s Medicines Co MDCO Stock Holding History

YorkBridge Wealth Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-81
Closed -$3K – 871
2018
Q2 		$3K Hold
81
– – ﹤0.01% 760
2018
Q1 		$3K Hold
81
– – ﹤0.01% 754
2017
Q4 		$2K Hold
81
– – ﹤0.01% 832
2017
Q3 		$3K Buy
+81
New +$2.99K ﹤0.01% 762

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YorkBridge Wealth Partners's MDCO Position: Q3 2018 in Review

YorkBridge Wealth Partners sold out of Medicines Co (MDCO) in Q3 2018, closing a stake of 81 shares — an estimated $3K sold.

YorkBridge Wealth Partners first reported a position in MDCO in Q3 2017 and held it in 4 quarters. The position peaked at $3K in Q2 2018. 184 funds tracked by Wall St. Rank hold MDCO as of Q3 2018.

  • YorkBridge Wealth Partners reported no remaining Medicines Co position as of Q3 2018 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 81 Medicines Co shares in Q3 2018, an estimated $3K.
  • YorkBridge Wealth Partners first reported a position in Medicines Co in Q3 2017 and held it in 4 quarters.
  • YorkBridge Wealth Partners's Medicines Co position peaked at $3K in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q3 2018.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.